In This Issue
Racial Differences in Lung Cancer Genetics
Alectinib Salvages CNS Relapses in ALK-Positive Lung Cancer Patients Previously Treated with Crizotinib and Ceritinib
Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring of Surveillance in Lung Cancer
Racial Diversity of Actionable Mutations in Non–Small Cell Lung Cancer
Neighborhood Deprivation and Lung Cancer Incidence and Mortality
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer
Role of Comorbidity on Survival after Radiotherapy and Chemotherapy for Nonsurgically Treated Lung Cancer
Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Prognostic Factors after Stereotactic Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer
Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer
Telomere Length and Recurrence Risk after Curative Resection in Patients with Early-Stage Non–Small-Cell Lung Cancer
Assessing the Multimodal Management of Advanced Solitary Fibrous Tumors of the Pleura in a Routine Practice Setting
Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base
Multimodality Guidance for Accurate Bronchoscopic Insertion of Fiducial Markers
Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non–Small-Cell Lung Cancer
Prognostic Nomogram to Predict Survival After Surgery for Synchronous Multiple Lung Cancers in Multiple Lobes
Tolerability of Nintedanib (BIBF 1120) in Combination with Docetaxel
Quality of Life Analyses from the Randomized, Open-Label, Phase III PointBreak Study of Pemetrexed-Carboplatin-Bevacizumab followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non–Small-Cell Lung Cancer
Detection of Human Polyomavirus 7 in Human Thymic Epithelial Tumors
The Impact of Thymoma Histotype on Prognosis in a Worldwide Database
Massively Parallel Sequencing Identifies Recurrent Mutations in TP53 in Thymic Carcinoma Associated with Poor Prognosis
A Mass Spectrometry Assay to Simultaneously Analyze ROS1 and RET Fusion Gene Expression in Non–Small-Cell Lung Cancer
SWOG S0722
Erlotinib Efficacy in NSCLC Patients with High Polysomy of Chromosome 7 and EGFR/KRas Wild-Type Tumors
Tumor Relapse After Thoracic Surgery?
Multiorgan Autoimmune Manifestations Associated with Thymoma
The Importance of Being Solid or Partially Solid for a Solitary Pulmonary Nodule
A Reply to Bertolaccini et al.
Difference in Outcome between Types of KRAS Mutation May Point toward Difference in Tumor Biology
KRAS-G12C Mutation is Associated with Poor Outcome in Surgically Resected Lung Adenocarcinoma